Predicting CFTR activity with front-runner cystic fibrosis drugs
- PMID: 26137547
- PMCID: PMC4485492
- DOI: 10.1016/j.ebiom.2015.01.013
Predicting CFTR activity with front-runner cystic fibrosis drugs
Comment on
-
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.EBioMedicine. 2014 Dec 17;2(2):147-53. doi: 10.1016/j.ebiom.2014.12.005. eCollection 2015. EBioMedicine. 2014. PMID: 26137539 Free PMC article.
References
-
- Balfour-Lynn I.M. Personalised medicine in cystic fibrosis is unaffordable. Paediatr. Respir. Rev. 2014;15(Suppl. 1):2–5. - PubMed
-
- Becq F. Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs. 2010;70:241–259. - PubMed
-
- Becq F., Mall M.A., Sheppard D.N., Conese M., Zegarra-Moran O. Pharmacological therapy for cystic fibrosis: from bench to bedside. J. Cyst. Fibros. 2011;(Suppl. 2):S129–S145. - PubMed
-
- Boyle M.P., De Boeck K. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. Lancet Respir. Med. 2013;1:158–163. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
